Skip to main content
. 2026 Jul 9;33(7):407. doi: 10.3390/curroncol33070407
CI Confidence Interval
CP Carboplatin/Paclitaxel
CRT Chemoradiotherapy
ECOG Eastern Cooperative Oncology Group
EP Cisplatin/Etoposide
HR Hazard Ratio
NLR Neutrophil-to-Lymphocyte Ratio
NSCLC Non-Small Cell Lung Cancer
OS Overall Survival
PFS Progression-Free Survival
PLR Platelet-to-Lymphocyte Ratio
PNI Prognostic Nutritional Index
SII Systemic Immune-Inflammation Index
TNM Tumor, Node, Metastasis